LSI - Life Science Intelligence™

We help Medtech leaders access the community, capital and insights that enable growth. Join us at our next event → LSI USA '26 March 16-20 in Dana Point

[LSI - Life Science Intelligence™ @lsintelligence]

LSI Alumni Weekly Recap is out now!

Featured in this week’s recap:

@AdagioMedical
Avisi Technologies
@BerlinHeals
@CapsMedical
@Dasisimulations
@Field_Medical_
@_INNITIUS
@lightHearted_AI
@NaluMed
@neurentmedical
@Neuroelectrics
@oxmedprod
@pleuraldynamics
@Pulse_Bio
@remedyrobotics
Smartlens

Read the full recap here: https://t.co/r2MgirK2bp

[LSI - Life Science Intelligence™ @lsintelligence]

Amira Romani’s full keynote from LSI Europe ‘25 is now available.

Amira Romani is Head of Innovation Strategy at @SiemensHealth and leads the global innovation ecosystem Siemens Healthineers SHIFT. In this role, she drives international collaboration with partners from research, industry, start-ups, and policy on key topics such as digital transformation, sustainability, and health equity. She also initiates and supports strategic consortium projects—such as improving stroke care in Europe—to foster impactful innovation in healthcare.

This session was moderated by Joe Mullings, Chairman & CEO of @MullingsGroup.

Watch the full session now on our website and YouTube channel.

[LSI - Life Science Intelligence™ @lsintelligence]

RevBio (#LSIAlumni) announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).

This two-year grant builds upon the work that was completed in a prior Phase I grant and will enable the company to complete preclinical product testing which is a key development step for obtaining approval from the FDA to initiate a human clinical trial.

Congratulations to Founder and CEO Brian Hess and the entire @RevBio_ team on another major milestone!

[LSI - Life Science Intelligence™ @lsintelligence]

Acorai (#LSIAlumni) announced positive results in a 1,600-patient CAPTURE-HF study for its AI-powered non-invasive platform for improved heart failure patient management.

Congratulations to CEO Filip Peters and the entire Acorai team on this impressive milestone.

Read more: https://t.co/U7cH0FJXd2

[LSI - Life Science Intelligence™ @lsintelligence]

Neuronoff (#LSIAlumni) announced the closure of an oversubscribed $4.5 million financing round to advance its Injectrode® platform toward FDA clearance and commercial launch.

The funding supports scaling production to 1,000 units annually and preparing for a limited U.S. launch in 2026 targeting interventional pain physicians, spinal surgeons, podiatrists, and other specialties treating chronic pain.

Congratulations to CEO Manfred Franke and the entire @Neuronoff team on this successful raise!

[LSI - Life Science Intelligence™ @lsintelligence]

Amira Romani’s full keynote from LSI Europe ‘25 is now available.

Amira Romani is Head of Innovation Strategy at @SiemensHealth and leads the global innovation ecosystem Siemens Healthineers SHIFT. In this role, she drives international collaboration with partners from research, industry, start-ups, and policy on key topics such as digital transformation, sustainability, and health equity. She also initiates and supports strategic consortium projects—such as improving stroke care in Europe—to foster impactful innovation in healthcare.

This session was moderated by @joemullings, Chairman & CEO of @MullingsGroup.

Watch the full session now.

[LSI - Life Science Intelligence™ @lsintelligence]

How can companies ensure their evidence strategy supports their path to market?

In this clip, Shai Ran Sapir highlights why both clinical and market evidence are essential to a company’s success. Generating strong clinical data is only part of the equation. Companies must also prove there’s a real market and that the problem they’re solving truly exists.

Watch the full session “Integrated Evidence Planning: Building a Roadmap for Development and Commercial Success”, now available on our website and YouTube, featuring:

- Joseph Ferrara — Chief Strategy Officer, @VeranexSolution
- Laurent Pacheco — Venture Partner, @SolasBio
- Bill Niland — CEO, ReGelTec
- Erin McEachren — Vice President & General Manager, Enabling Technologies: Cranial and Spinal Technologies, @Medtronic
- Pablo Morales — Former FDA
- Shai Ran Sapir — Technology Development Manager - Cardiovascular Lead, @MayoClinic

#LSIEurope25

[LSI - Life Science Intelligence™ @lsintelligence]

Dova Health Intelligence Inc. (#LSIAlumni)announced a collaboration with Mayo Clinic to advance the development and validation of its DovaVision UC Mayo Endoscopic Score (MES), an artificial intelligence tool designed for more precise and reproducible scoring of ulcerative colitis disease activity from colonoscopy videos.

Congratulations to CEO Solveig Johannessen, and the entire team on this collaboration!

https://t.co/a25fSgiDs2

[LSI - Life Science Intelligence™ @lsintelligence]

Xenocor (#LSIAlumni) has announced the issuance of U.S. Patent No. 12,429,685 B2 for its innovative medical borescope and tip assembly technology.

The newly granted patent covers a range of novel features, including the integration of electromagnetic interference (EMI) shielding within the Saberscope® tip assembly.

Congratulations to LSI Alumni and COO, Tony Watson, and the entire Xenocor team!

https://t.co/6uKffMcA1i

[LSI - Life Science Intelligence™ @lsintelligence]

Vektor Medical (#LSIAlumni) announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute.

Congratulations to CEO Rob Krummen, and the entire @VektorMedical team!

https://t.co/Hqm8n4i2ZK

[LSI - Life Science Intelligence™ @lsintelligence]

New LSI Europe ‘25 panel released — Integrated Evidence Planning: Building a Roadmap for Development and Commercial Success

This panel explored how companies can design evidence strategies that support both product approval and market adoption. With perspectives from strategy, investment, clinical development, regulation, and commercialization, the discussion highlighted what it takes to align stakeholders and build a roadmap that drives long-term success.

This session featured:

- Joseph Ferrara — Chief Strategy Officer, @VeranexSolution
- Laurent Pacheco — Venture Partner, @SolasBio
- Bill Niland — CEO, ReGelTec
- Erin McEachren — Vice President & General Manager, Enabling Technologies: Cranial and Spinal Technologies, @Medtronic
- Pablo Morales — Former FDA
- Shai Ran Sapir — Technology Development Manager - Cardiovascular Lead, @MayoClinic

Watch the full LSI Europe ‘25 session, now available.

[LSI - Life Science Intelligence™ @lsintelligence]

AtaCor Medical (#LSIAlumni) has secured financing of up to $75 million.

The proceeds will fund the company's U.S. FDA Pivotal Study evaluating AtaCor's parasternal extravascular implantable cardioverter-defibrillator (EV-ICD) system for the treatment of life-threatening ventricular tachyarrhythmias.

Congratulations to CEO Rick Sanghera, and the entire @AtaCorMedical team on this new financing!

[LSI - Life Science Intelligence™ @lsintelligence]

What inspired @HarryStebbings to launch @20vcFund?

Driven by his passion for technology, finance, and venture, Harry Stebbings started 20VC from his bedroom at just 18 years old. His journey was also deeply personal. After his mother was diagnosed with multiple sclerosis, he set out to raise $2 million in a single weekend to help cover the cost of her treatment.

Hear Harry share the full story, and much more, in his Signature Series from LSI Europe ‘25, now available on our website and YouTube channel.

Thank you, Harry, for sharing your story and helping us close out the final day of LSI Europe ‘25 with your insights on venture and the entrepreneurs shaping the future.

[LSI - Life Science Intelligence™ @lsintelligence]

MediView XR (#LSIAlumni) announced the close of its $24 million Series A funding round led by GE HealthCare.

The round also included investment from Cleveland Clinic, Mayo Clinic, Edge Ventures, the investment arm of Emplify Health, and JobsOhio Growth Capital Fund.

Congratulations to CEO & President, Mina Fahim, and the entire @MediViewXR team on the successful Series A raise!

[Caresyntax @caresyntax]

At #LSIUSA, @bruceramshawmd shared how Caresyntax helps hospitals “do data differently” by linking surgical, financial, and patient outcome data to show true value.

Watch the full fireside chat 🎥:
https://t.co/DlDYXKgSFe

[LSI - Life Science Intelligence™ @lsintelligence]

Oath Surgical (@OathSurgical) announced an oversubscribed $24M Series A led by FPV Ventures.

This round also included participation from McKesson Ventures and existing investors OSE, Black Opal Ventures, Tau Ventures, and Rogue VC, bringing total funding to $35M.

Congratulations to LSI Alumni Dr. Oliver Keown, Founder and CEO of Oath Surgical, and the entire team on a successful Series A!

Read more about Oath Surgical in The Memo, released earlier this year: https://t.co/vkcniK2aVG

[LSI - Life Science Intelligence™ @lsintelligence]

A new edition of The Memo is out now!

This week, we dove into the origin story, market landscape, device details, and key milestones for @DeepSightInc, featuring Founder and CEO Nader Sadrzadeh.

With its NeedleVue™ technology, DeepSight is positioning ultrasound not just as a diagnostic aid, but as a central guidance system for minimally invasive therapies.

Read the full article: https://t.co/5TOX0qDxD2

[LSI - Life Science Intelligence™ @lsintelligence]

Do you learn more from success or from failure?

Andrew Chung: “I had lunch with one of the partners from Benchmark, a long time ago, Andy Ratcliffe, who I respect a great deal. And he told me, and I agree, that you learn more from successes, not failures.”

Catch the full closing Fireside Chat with @achung, Founder & Managing Partner of @1955Capital, in conversation with Addie Harris. Now available on our website and YouTube channel.

[LSI - Life Science Intelligence™ @lsintelligence]

LSI Alumni Weekly Recap is out now!

Featured in this week’s recap:

@AdagioMedical
@AiMMedRobotics
@CorWave
@Cyber_Surgery
@DeepSightInc
@DermaSenso
@Distalmotion
@ENDOQUESTRobot
@FluidAIMedical
@IbexMedAx
Navigation Sciences
Panda Surgical
Pylon Medical
@SpectraWAVE_Med
@VicariousSurg

Read the full recap here: https://t.co/w3U5CsmiiX

[LSI - Life Science Intelligence™ @lsintelligence]

Closing Fireside Chat with @achung , Founder & Managing Partner of @1955Capital is now live.

This session was the perfect way to wrap up an incredible week in London. Thank you Andrew and Addie Harris for this incredible session.

Andrew has been a tech investor and entrepreneur for over 20 years with rare experience and success investing in sustainability and health technology. He was involved with 8 unicorns in world-positive sectors while at Khosla Ventures and Lightspeed Ventures that have created over $30 billion of market value.

He founded 1955 Capital to invest in revolutionary technologies to solve the greatest global challenges of our time. 1955 was the largest venture capital firm debut in Q1 2016 and focuses on sustainability (energy, food, agriculture), education, health, and other emerging technologies.

As a thought leader in sustainable technology and U.S.-Asia collaboration, Andrew served on a White House roundtable on advanced manufacturing during the Obama Administration and has advised global leaders on energy policy. He has given talks on the future of food and energy, moonshot entrepreneurship, translating university research, ESG investing, and U.S.-Asia relations at numerous global conferences.